In this study, we examined the utility of molecular classification based on the IDH and TERT statuses to predict clinical courses of patients in association with various clinical factors, histological diagnosis, and grading in a large series of newly diagnosed WHO grade II-IV adult gliomas. The gene discussed is TERT; the disease is glioma.